SCHEMBL5199733

SCHEMBL5199733

CN(CC1CC1)C1CCCC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA1B P35368 1/20 0.41
HRH4 Q9H3N8 1/20 0.41
HRH3 Q9Y5N1 1/20 0.41
TMEM97 Q5BJF2 5/20 0.38
ADH1C P00326 2/20 0.36
ADH1A P07327 2/20 0.36
KDM4E B2RXH2 1/20 0.35
SIGMAR1 Q99720 2/20 0.35
ABCB11 O95342 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
AR P10275 1/20 0.33
CYP2D6 P10635 1/20 0.33
SLC6A2 P23975 1/20 0.33
PDE4A P27815 1/20 0.33
SLC6A4 P31645 1/20 0.33
SLC6A3 Q01959 1/20 0.33
KCNH2 Q12809 1/20 0.33
ALDH1A1 P00352 1/20 0.33
ALOX5 P09917 2/20 0.32
FAAH O00519 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13280102 0.97 ADRA1B (0.44) ADRA1BHRH4HRH3TMEM97ADH1C
SCHEMBL5626469 0.97 ADRA1B (0.38) ADRA1BHRH4HRH3TMEM97ADH1C
SCHEMBL13711851 0.95 ADRA1B (0.46) ADRA1BHRH4HRH3TMEM97ADH1C
SCHEMBL13711904 0.92 ADRA1B (0.48) ADRA1BHRH4HRH3TMEM97ADH1C
SCHEMBL19720283 0.92 ADRA1B (0.48) ADRA1BHRH4HRH3TMEM97ADH1C
SCHEMBL27694563 0.90 ADRA1B (0.46) ADRA1BHRH4HRH3TMEM97KDM4E
SCHEMBL21088841 0.90 ADRA1B (0.41) ADRA1BHRH4HRH3TMEM97ADH1C
SCHEMBL9941985 0.89
SCHEMBL3439991 0.87 ADRA1B (0.48) ADRA1BHRH4HRH3TMEM97ADH1C
SCHEMBL24079741 0.85 TMEM97 (0.39) ADRA1BHRH4HRH3TMEM97SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1737823-A2 NOVEL ALKYNE COMPOUNDS WITH AN MCH-ANTAGONISTIC ACTION AND MEDICAMENTS COMPRISING SAID COMPOUNDS Boehringer Ingelheim International GmbH (DE) 2007-01-03 EP claimed
WO-2005103002-A2 NOVEL ALKYNE COMPOUNDS WITH AN MCH-ANTAGONISTIC ACTION AND MEDICAMENTS COMPRISING SAID COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-11-03 WO claimed
US-7592358-B2 Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-09-22 US disclosed
EP-1737823-A2 NOVEL ALKYNE COMPOUNDS WITH AN MCH-ANTAGONISTIC ACTION AND MEDICAMENTS COMPRISING SAID COMPOUNDS Boehringer Ingelheim International GmbH (DE) 2007-01-03 EP disclosed
WO-2005103002-A2 NOVEL ALKYNE COMPOUNDS WITH AN MCH-ANTAGONISTIC ACTION AND MEDICAMENTS COMPRISING SAID COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-11-03 WO disclosed